Since the beginning of this millennium we have seen antibiotic R&D dwindle year after year. There are many reasons for this; while economics are often cited for this decline, the FDA and the ‘Guideline Wars’, i.e., those never ending discussions
Continue reading Progress Report: New Antibacterials In the Fight against MDR Bacteria → Like this: Like Loading...
Posted in Recent Literature, The News, The Viewpoint |
Tagged '10 x '20 initiative, ABSSSI, Allergan, antibiotic approvals, antibiotic blog, antibiotic pipeline, AstraZeneca, avibactam, Avycaz, Bayer, bedaquiline, BI/BLI combination, BLI, BMS, CABP, ceftaroline, Ceftazidime/avibactam, ceftolozane/tazobactam, cIAI, colistin, CRE, Cubicin, cUTI, dalbavancin, Dalvance, daptomycin, Dificid, Durata, EMA, ESBL, ESKAPE, expedited review, Fast Track, FDA, FDA Guidance, fidaxomicin, GSK, Harald Reinhart, IDSA, IMI, Johnson & Johnson, MDR pathogens, MDR-TB, MRSA, non-inferiority margins, novel antibiotics, Novexel, Orbactiv, oritavancin, P. aeruginosa, patient-reported outcomes, penem, Pfizer, PRO, QIDP, Roche, Sanofi, Sirturo, Sivextro, tazobactam, tedizolid, Teflaro, The Medicines Company, tuberculosis, vancomycin, Zinforo |
In the last decade (2000-2010), we saw the number of new antibiotic approvals drop successively each year; FDA changed the rules of the approval process without providing public guidance; many antibiotic companies fled the therapeutic area; investments were redirected to
Continue reading The 10 x ’20 Goal – Are We On Track? → Like this: Like Loading...
Posted in The News, The Viewpoint |
Tagged Allphase Pharma Consulting, antibiotic blog, antibiotic pipeline, AstraZeneca, Avycaz, aztreonam/avibactam, Basilea, Bayer, bedaquiline, ceftaroline, Ceftazidime/avibactam, ceftolozane/tazobactam, dalbavancin, Dalvance, defensin, delafloxacin, Dificid, eravacycline, FabI inhibitor, fidoxamicin, Harald Reinhart, MDR drugs, Merck, omadacycline, Orbactiv, oritavancin, Paratek, Pfizer, POL7080, Polyphor, Roche, Shionogi, Sirturo, Sivextro, tedizolid, televancin, Tetraphase, Vibativ, Zerbaxa, Zinforo |